Evidence map›Paper›PMID 41809448›Full record

ArticleWorld journal of gastroenterology2026

Growth differentiation factor 11 reprograms M2-like macrophages: Targeting immunometabolism for cancer therapy.

Saeed Mohammadi, Mahmoud Darweesh, Ahmed Al-Harrasi

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Saeed MohammadiNatural and Medical Sciences Research Center, University of Nizwa, Nizwa 616, Ad Dakhiliyah, Oman.
Mahmoud DarweeshNatural and Medical Sciences Research Center, University of Nizwa, Nizwa 616, Ad Dakhiliyah, Oman.
Ahmed Al-HarrasiNatural and Medical Sciences Research Center, University of Nizwa, Nizwa 616, Ad Dakhiliyah, Oman. aharrasi@unizwa.edu.om.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This editorial comments on recent research by Escobedo-Calvario

Indexed as

Bone Morphogenetic ProteinsCarcinoma, HepatocellularGrowth Differentiation FactorsLiver NeoplasmsMacrophagesTumor-Associated MacrophagesAnimalsAntineoplastic AgentsHumansMetabolic ReprogrammingReactive Oxygen SpeciesSignal TransductionTumor MicroenvironmentAntineoplastic AgentsBone Morphogenetic ProteinsGDF11 protein, humanGrowth Differentiation FactorsReactive Oxygen SpeciesCancerGrowth differentiation factor 11Hepatocellular carcinomaImmunometabolismMacrophage polarizationMacrophagesTumor microenvironment

Identifiers

PMID41809448
PMCPMC12968600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.